 Douglas Kemme
Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 1 | 2023 | 230 | 0.160 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 413 | 0.140 |
Why?
| | Nitrofurantoin | 1 | 2014 | 9 | 0.100 |
Why?
| | Anti-Infective Agents, Urinary | 1 | 2014 | 16 | 0.100 |
Why?
| | Cystitis | 1 | 2014 | 24 | 0.100 |
Why?
| | Aminoglycosides | 1 | 1993 | 30 | 0.090 |
Why?
| | Sezary Syndrome | 1 | 1992 | 45 | 0.090 |
Why?
| | Mycosis Fungoides | 1 | 1992 | 63 | 0.090 |
Why?
| | Arteriovenous Malformations | 1 | 1991 | 32 | 0.080 |
Why?
| | Coronary Vessel Anomalies | 1 | 1991 | 38 | 0.080 |
Why?
| | Angina, Unstable | 1 | 1991 | 83 | 0.080 |
Why?
| | Lung Diseases, Interstitial | 1 | 2014 | 664 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2014 | 925 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 1992 | 849 | 0.050 |
Why?
| | Anilides | 1 | 2023 | 84 | 0.050 |
Why?
| | Lung | 1 | 2014 | 4106 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2664 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 1992 | 2214 | 0.040 |
Why?
| | Pyridines | 1 | 2023 | 609 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2023 | 992 | 0.030 |
Why?
| | Cryptogenic Organizing Pneumonia | 1 | 2014 | 20 | 0.030 |
Why?
| | Carmustine | 1 | 1994 | 52 | 0.030 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2014 | 53 | 0.030 |
Why?
| | Cough | 1 | 2014 | 124 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 1994 | 270 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1993 | 49 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2014 | 343 | 0.020 |
Why?
| | Dyspnea | 1 | 2014 | 250 | 0.020 |
Why?
| | Cisplatin | 1 | 1994 | 345 | 0.020 |
Why?
| | Fatigue | 1 | 2014 | 364 | 0.020 |
Why?
| | Cineangiography | 1 | 1991 | 9 | 0.020 |
Why?
| | Endocardium | 1 | 1991 | 31 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2014 | 1471 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1508 | 0.020 |
Why?
| | Drug Monitoring | 1 | 1993 | 401 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 1992 | 1266 | 0.020 |
Why?
| | Kidney Diseases | 1 | 1993 | 425 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 858 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1808 | 0.020 |
Why?
| | Electrocardiography | 1 | 1991 | 665 | 0.020 |
Why?
| | Middle Aged | 3 | 2014 | 36215 | 0.010 |
Why?
| | Humans | 5 | 2023 | 145474 | 0.010 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1189 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2769 | 0.010 |
Why?
| | Prospective Studies | 1 | 1993 | 8057 | 0.010 |
Why?
| | Female | 3 | 2014 | 78844 | 0.010 |
Why?
| | Drug Interactions | 1 | 1994 | 405 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 1994 | 782 | 0.010 |
Why?
| | Adult | 1 | 1993 | 40777 | 0.000 |
Why?
| | Male | 2 | 1994 | 72842 | 0.000 |
Why?
| | Rats, Sprague-Dawley | 1 | 1994 | 2524 | 0.000 |
Why?
| | Rats | 1 | 1994 | 5584 | 0.000 |
Why?
| | Animals | 1 | 1994 | 38030 | 0.000 |
Why?
|
|
Kemme's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|